Adenocyte is a medical technology company dedicated to revolutionizing the field of cytopathology through advanced ultrasound innovation. We are the pioneers of LINFU (Low-Intensity Focused Ultrasound) technology, a breakthrough approach designed to enhance the precision, safety, and effectiveness of biopsy procedures.
Our Mission is to bridge the gap between complex diagnostics and clinical execution. By developing a specialized medical workstation and high-precision ultrasound probes, we enable clinicians to obtain higher-quality biological samples with improved cell viability. We believe that better sampling leads to better data, and better data leads to life-saving diagnoses.

Innovation at our Core At Adenocyte, we are currently in the preclinical stage, focusing on the development and validation of our proprietary LINFU platform. Our multidisciplinary team of engineers and scientists is committed to meeting the highest regulatory standards—including ISO 13485 and IEC 60601—as we move toward our FDA  submission.

Based in Israel and USA with a global vision, Adenocyte is actively collaborating with leading engineering houses and clinical laboratories to bring our vision to the operating room. We are driven by the belief that every cell tells a story, and we provide the tools to hear it clearly.

Adenocyte

Org chart

Teams

Offices

Adenocyte

Org chart

Teams

Offices

Related companies